Role of Nuclear Imaging to Understand the Neural Substrates of Brain Disorders in Laboratory Animals: Current Status and Future Prospects
暂无分享,去创建一个
Roberto Massari | Annunziata D'Elia | Sara Schiavi | Andrea Soluri | Alessandro Soluri | Viviana Trezza | V. Trezza | A. Soluri | A. D'Elia | R. Massari | S. Schiavi | A. Soluri
[1] Sushil K. Sharma,et al. SPECT neuroimaging in translational research of CNS disorders , 2008, Neurochemistry International.
[2] David J. Schlyer,et al. RatCAP: a small, head-mounted PET tomograph for imaging the brain of an awake RAT , 2004 .
[3] J T Williams,et al. Cellular and synaptic adaptations mediating opioid dependence. , 2001, Physiological reviews.
[4] G. Bormans,et al. An in vivo [18F]MK-9470 microPET study of type 1 cannabinoid receptor binding in Wistar rats after chronic administration of valproate and levetiracetam , 2008, Neuropharmacology.
[5] D J Brooks,et al. L‐Dihydroxyphenylalanine and its decarboxylase: New ideas on their neuroregulatory roles , 1995, Movement disorders : official journal of the Movement Disorder Society.
[6] Lu Wang,et al. In Vitro and in Vivo Evaluation of 11C-Labeled Azetidinecarboxylates for Imaging Monoacylglycerol Lipase by PET Imaging Studies. , 2018, Journal of medicinal chemistry.
[7] Hans Herzog,et al. Advances in Clinical PET/MRI Instrumentation. , 2016, PET clinics.
[8] Mahmood Akhtar,et al. Open-field PET: Simultaneous brain functional imaging and behavioural response measurements in freely moving small animals , 2019, NeuroImage.
[9] Paul Vaska,et al. Integrating PET with behavioral neuroscience using RatCAP tomography , 2011, Reviews in the neurosciences.
[10] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[11] H. M. Deloar,et al. System design and development of a pinhole SPECT system for quantitative functional imaging of small animals , 2006, Annals of nuclear medicine.
[12] S. Siegel,et al. Performance evaluation of the microPET focus: a third-generation microPET scanner dedicated to animal imaging. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] B R Rosen,et al. Detection of the effects of dopamine receptor supersensitivity using pharmacological MRI and correlations with PET , 2000, Synapse.
[14] F. Beekman,et al. SPECT imaging of D2 dopamine receptors and endogenous dopamine release in mice , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[15] U. Himmelreich,et al. Metabolic and Type 1 cannabinoid receptor imaging of a transgenic rat model in the early phase of Huntington disease , 2011, Experimental Neurology.
[16] Patrick Dupont,et al. [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor , 2007, Proceedings of the National Academy of Sciences.
[17] G. Nikiforidis,et al. In vivo small animal imaging: current status and future prospects. , 2010, Medical physics.
[18] M. Catherine Bushnell,et al. Rodent functional and anatomical imaging of pain , 2012, Neuroscience Letters.
[19] A. Del Guerra,et al. YAP-PET: first results of a small animal positron emission tomograph based on YAP:Ce finger crystals , 1998 .
[20] Horst Halling,et al. Compact high resolution detector for small animal SPECT , 1999, 1999 IEEE Nuclear Science Symposium. Conference Record. 1999 Nuclear Science Symposium and Medical Imaging Conference (Cat. No.99CH37019).
[21] A. Savonenko,et al. Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation , 2015, PloS one.
[22] D Cuthbertson,et al. Metabolic changes. , 1970, Journal of clinical pathology. Supplement.
[23] S. Glaser,et al. Imaging of the brain cannabinoid system. , 2005, Handbook of experimental pharmacology.
[24] N. Volkow,et al. Translational neuroimaging in drug addiction and obesity. , 2012, ILAR journal.
[25] J. Mukherjee,et al. Evaluation of serotonin 5‐HT1A receptors in rodent models using [18F]mefway PET , 2013, Synapse.
[26] C. Antke,et al. A landmark-based approach for the quantitation of receptor and transporter binding in the rat using small animal SPECT and PET , 2004, IEEE Symposium Conference Record Nuclear Science 2004..
[27] Sophie Lancelot,et al. Small-animal positron emission tomography as a tool for neuropharmacology. , 2010, Trends in pharmacological sciences.
[28] Nathalie Ginovart,et al. PET study of the [11C]raclopride binding in the striatum of the awake cat: effects of anaesthetics and role of cerebral blood flow , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[29] P. T. Fox,et al. Positron emission tomographic studies of the cortical anatomy of single-word processing , 1988, Nature.
[30] S. Nishiyama,et al. Sustained Withdrawal Allows Normalization of In Vivo [11C]N-Methylspiperone Dopamine D2 Receptor Binding after Chronic Binge Cocaine: A Positron Emission Tomography Study in Rats , 1998, Neuropsychopharmacology.
[31] P. Acton,et al. Quantification of dopamine transporters in the mouse brain using ultra-high resolution single-photon emission tomography , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[32] J. Rinne,et al. [18F]FMPEP-d 2 PET imaging shows age- and genotype-dependent impairments in the availability of cannabinoid receptor 1 in a mouse model of Alzheimer's disease , 2018, Neurobiology of Aging.
[33] L. Furenlid,et al. SPECT detectors: the Anger Camera and beyond , 2011, Physics in medicine and biology.
[34] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[35] C. D. Richards,et al. Excitatory and inhibitory synaptic mechanisms in anaesthesia. , 1993, British journal of anaesthesia.
[36] P. Acton,et al. Small-Animal SPECT and SPECT/CT: Important Tools for Preclinical Investigation* , 2008, Journal of Nuclear Medicine.
[37] Markus Rudin,et al. Noninvasive structural, functional, and molecular imaging in drug development. , 2009, Current opinion in chemical biology.
[38] N. Volkow,et al. Effects of chronic methamphetamine on psychomotor and cognitive functions and dopamine signaling in the brain , 2017, Behavioural Brain Research.
[39] M. Bushnell,et al. Chronic neuropathic pain reduces opioid receptor availability with associated anhedonia in rat , 2018, Pain.
[40] C. Scherfler,et al. Small animal imaging using a conventional gamma camera exemplified in studies on the striatal dopaminergic system. , 2006, Nuclear medicine review. Central & Eastern Europe.
[41] J. Fernández-Ruiz,et al. Targeting cannabinoid CB2 receptors in the Central Nervous System. Medicinal chemistry approaches and focus on neurodegenerative disorders affecting movement , 2016 .
[42] Huafeng Wei,et al. Isoflurane Causes Greater Neurodegeneration Than an Equivalent Exposure of Sevoflurane in the Developing Brain of Neonatal Mice , 2010, Anesthesiology.
[43] A. Rehemtulla,et al. Molecular Imaging , 2009, Methods in Molecular Biology.
[44] J. Booij,et al. Evaluation of high-resolution pinhole SPECT using a small rotating animal. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[45] K. Laere. In vivo imaging of the endocannabinoid system: a novel window to a central modulatory mechanism in humans , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[46] Guy Bormans,et al. Kinetic analysis of the cannabinoid-1 receptor PET tracer [18F]MK-9470 in human brain , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[47] H. Lu,et al. Resting-State Functional Connectivity in Rat Brain , 2005 .
[48] M. Senda,et al. KF 18446 PET in the rat brain after quinolinic acid lesion : Comparison with the dopamine receptor imaging , 2002 .
[49] L. Shah,et al. Functional magnetic resonance imaging. , 2010, Seminars in roentgenology.
[50] A. Soluri,et al. Preliminary results on a small animal SPECT system based on H13700 PSMPT coupled with CRY018 array , 2019, Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment.
[51] K. Miller,et al. Mechanisms of actions of inhaled anesthetics. , 2003, The New England journal of medicine.
[52] R. Buchert,et al. [123I]AM281 single-photon emission computed tomography imaging of central cannabinoid CB1 receptors before and after Δ9-tetrahydrocannabinol therapy and whole-body scanning for assessment of radiation dose in tourette patients , 2004, Biological Psychiatry.
[53] Payton King,et al. Imaging the Brain Marijuana Receptor: Development of a Radioligand that Binds to Cannabinoid CB1 Receptors In Vivo , 1998, Journal of neurochemistry.
[54] J. Olney,et al. Early Exposure to Common Anesthetic Agents Causes Widespread Neurodegeneration in the Developing Rat Brain and Persistent Learning Deficits , 2003, The Journal of Neuroscience.
[55] N. Volkow,et al. Addiction: Decreased reward sensitivity and increased expectation sensitivity conspire to overwhelm the brain's control circuit , 2010, BioEssays : news and reviews in molecular, cellular and developmental biology.
[56] Sepideh Shokouhi,et al. Advances in Preclinical SPECT Instrumentation , 2012, The Journal of Nuclear Medicine.
[57] R. G. Correa,et al. Dopamine: Functions, Signaling, and Association with Neurological Diseases , 2018, Cellular and Molecular Neurobiology.
[58] Roger Lecomte,et al. Technology challenges in small animal PET imaging , 2004 .
[59] Hao Wu,et al. PET Imaging Reveals Brain Metabolic Changes in Adolescent Rats Following Chronic Escalating Morphine Administration , 2018, Molecular Imaging and Biology.
[60] P. Willner,et al. The validity of animal models of depression , 2004, Psychopharmacology.
[61] L. Vanderschuren,et al. Opioids, reward and addiction: An encounter of biology, psychology, and medicine. , 1999, Pharmacological reviews.
[62] M. Rodriguez-Porcel. In Vivo Imaging and Monitoring of Transplanted Stem Cells: Clinical Applications , 2010, Current cardiology reports.
[63] Bernd J. Pichler,et al. Quantitative Rodent Brain Receptor Imaging , 2019, Molecular Imaging and Biology.
[64] S. Meikle,et al. Small animal SPECT and its place in the matrix of molecular imaging technologies , 2005, Physics in medicine and biology.
[65] Paul M. Grasby,et al. A positron emission tomography (PET) investigation of the role of striatal dopamine (D2) receptor availability in spatial cognition , 2005, NeuroImage.
[66] Roger N. Gunn,et al. Pharmacological constraints associated with positron emission tomographic scanning of small laboratory animals , 1998, European Journal of Nuclear Medicine.
[67] Donald W. Wilson,et al. Quantitative analysis of acute myocardial infarct in rat hearts with ischemia-reperfusion using a high-resolution stationary SPECT system. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[68] M Jarmasz,et al. Functional magnetic resonance imaging in rats subjected to intense electrical and noxious chemical stimulation of the forepaw , 2000, Pain.
[69] Simon R. Cherry,et al. Deficits in Striatal Dopamine D2 Receptors and Energy Metabolism Detected by in Vivo MicroPET Imaging in a Rat Model of Huntington's Disease , 2000, Experimental Neurology.
[70] Seong-Gi Kim,et al. Relationship between neural, vascular, and BOLD signals in isoflurane-anesthetized rat somatosensory cortex. , 2006, Cerebral cortex.
[71] A. Grace. Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression , 2016, Nature Reviews Neuroscience.
[72] Koen Van Laere,et al. Relationship of type 1 cannabinoid receptor availability in the human brain to novelty-seeking temperament. , 2009, Archives of general psychiatry.
[73] Cristina Lavini,et al. Imaging of striatal dopamine transporters in rat brain with single pinhole SPECT and co-aligned MRI is highly reproducible. , 2003, Nuclear medicine and biology.
[74] G. Fox,et al. Characterization of a Cannabinoid CB2 Receptor-Selective Agonist, A-836339 [2,2,3,3-Tetramethyl-cyclopropanecarboxylic Acid [3-(2-Methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], Using in Vitro Pharmacological Assays, in Vivo Pain Models, and Pharmacological Magnetic Resonance Imaging , 2009, Journal of Pharmacology and Experimental Therapeutics.
[75] Michael L Lipton,et al. Imaging devices for use in small animals. , 2011, Seminars in nuclear medicine.
[76] Floris P Jansen,et al. The future of SPECT in a time of PET. , 2007, Nuclear medicine and biology.
[77] A. Savonenko,et al. Synthesis and biodistribution of [11C]A-836339, a new potential radioligand for PET imaging of cannabinoid type 2 receptors (CB2). , 2010, Bioorganic & medicinal chemistry.
[78] J. Pratte,et al. Simultaneous assessment of rodent behavior and neurochemistry using a miniature positron emission tomograph , 2011, Nature Methods.
[79] B. Cornelissen,et al. A review of small animal imaging planar and pinhole spect Gamma camera imaging. , 2005, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.
[80] F. Jaw,et al. Brain nociceptive imaging in rats using 18f-fluorodeoxyglucose small-animal positron emission tomography , 2008, Neuroscience.
[81] S. Ametamey,et al. Discovery of a fluorinated 4‐oxo‐quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2 , 2016, Journal of neurochemistry.
[82] G. Bormans,et al. Small animal PET imaging of the type 1 cannabinoid receptor in a rodent model for anorexia nervosa , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[83] T G Turkington,et al. Introduction to PET instrumentation. , 2001, Journal of nuclear medicine technology.
[84] N. Vanitha,et al. positron emission tomography in neuroscience research , 2011, Annals of neurosciences.
[85] Jeih-San Liow,et al. Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand , 2009, NeuroImage.
[86] Paul H. E. Tiesinga,et al. The Scalable Brain Atlas: Instant Web-Based Access to Public Brain Atlases and Related Content , 2013, Neuroinformatics.
[87] P. Hantraye. Modeling dopamine system dysfunction in experimental animals. , 1998, Nuclear medicine and biology.
[88] P. Kulkarni,et al. Oxycodone Exposure: A Magnetic Resonance Imaging Study in Response to Acute and Chronic Oxycodone Treatment in Rats , 2019, Neuroscience.
[89] Willy Gsell,et al. Anaesthesia and physiological monitoring during in vivo imaging of laboratory rodents: considerations on experimental outcomes and animal welfare , 2012, EJNMMI Research.
[90] Tibor Kovács,et al. State of the art in vivo imaging techniques for laboratory animals , 2017, Laboratory animals.
[91] C. H. Summers,et al. The role of behavior in translational models for psychopathology: Functionality and dysfunctional behaviors , 2013, Neuroscience & Biobehavioral Reviews.
[92] Dean F. Wong,et al. Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR , 2010, NeuroImage.
[93] David J. Brooks,et al. Positron emission tomography and single-photon emission computed tomography in central nervous system drug development , 2005, NeuroRX.
[94] Domingos Vieira,et al. Preclinical Imaging: an Essential Ally in Modern Biosciences , 2013, Molecular Diagnosis & Therapy.
[95] Simon R. Cherry,et al. Development and evaluation of an automated atlas-based image analysis method for microPET studies of the rat brain , 2003, NeuroImage.
[96] Yuan-Chuan Tai,et al. Instrumentation aspects of animal PET. , 2005, Annual review of biomedical engineering.
[97] D. Piomelli. The molecular logic of endocannabinoid signalling , 2003, Nature Reviews Neuroscience.
[98] Vinal D. Patel,et al. Metabolic Changes in the Rodent Brain after Acute Administration of Salvinorin A , 2009, Molecular Imaging and Biology.
[99] F. Beekman,et al. Submillimeter total-body murine imaging with U-SPECT-I. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[100] R. Pearlstein,et al. Isoflurane-Induced Neuronal Degeneration: An Evaluation in Organotypic Hippocampal Slice Cultures , 2005, Anesthesia and analgesia.
[101] C. Zippe,et al. Evaluation of preoperative ProstaScint™ scans in the prediction of nodal disease , 2002, Prostate Cancer and Prostatic Diseases.
[102] L. Sokoloff,et al. Effects of anesthesia on functional activation of cerebral blood flow and metabolism , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[103] D. Kraitchman,et al. Recent Advances in Small-Animal Cardiovascular Imaging , 2009, Journal of Nuclear Medicine.
[104] C. Antke,et al. In vivo imaging of synaptic function in the central nervous system I. Movement disorders and dementia , 2009, Behavioural Brain Research.
[105] A. Müller-Lutz,et al. Amantadine enhances nigrostriatal and mesolimbic dopamine function in the rat brain in relation to motor and exploratory activity , 2019, Pharmacology Biochemistry and Behavior.
[106] H. Wey,et al. Immediate and Persistent Effects of Salvinorin A on the Kappa Opioid Receptor in Rodents, Monitored In Vivo with PET , 2015, Neuropsychopharmacology.
[107] Differential regulation of brain opioid receptors following repeated cocaine administration to guinea pigs. , 1993, Drug and alcohol dependence.
[108] G. Antoni,et al. 18F-ML-10, a PET Tracer for Apoptosis: First Human Study , 2011, The Journal of Nuclear Medicine.
[109] Roger Lecomte,et al. Initial studies using the RatCAP conscious animal PET tomograph , 2007 .
[110] S. Obayashi,et al. In Vivo PET Measurements with [11C]PE2I to Evaluate Fetal Mesencephalic Transplantations to Unilateral 6-OHDA-Lesioned Rats , 2005, Cell transplantation.
[111] M. Pomper,et al. Development of a High-Affinity PET Radioligand for Imaging Cannabinoid Subtype 2 Receptor. , 2016, Journal of medicinal chemistry.
[112] Anne Lingford-Hughes,et al. Using [11C]Diprenorphine to Image Opioid Receptor Occupancy by Methadone in Opioid Addiction: Clinical and Preclinical Studies , 2005, Journal of Pharmacology and Experimental Therapeutics.
[113] Lijie Wu,et al. Role of the endocannabinoid system in neurological disorders , 2019, International Journal of Developmental Neuroscience.
[114] G. Trinci,et al. Super Spatial Resolution (SSR) method for scintigraphic imaging , 2011 .
[115] S. Nishiyama,et al. Effects of Binge Pattern Cocaine Administration on Dopamine D1 and D2 Receptors in the Rat Brain: AnIn Vivo Study Using Positron Emission Tomography , 1996, The Journal of Neuroscience.
[116] L. Herbst,et al. Small-animal research imaging devices. , 2014, Seminars in nuclear medicine.
[117] D. Dione,et al. Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction. , 2004, The Journal of clinical investigation.
[118] Aileen Schroeter,et al. Optimization of anesthesia protocol for resting-state fMRI in mice based on differential effects of anesthetics on functional connectivity patterns , 2014, NeuroImage.
[119] Wang Xi,et al. Molecular imaging in neuroscience research with small-animal PET in rodents , 2011, Neuroscience Research.
[120] Pedro Rosa-Neto,et al. MicroPET imaging and transgenic models: a blueprint for Alzheimer's disease clinical research , 2014, Trends in Neurosciences.
[121] Xiaoyuan Chen,et al. PET Imaging of Angiogenesis. , 2009, PET clinics.
[122] R. Boisgard,et al. PET imaging of cannabinoid type 2 receptors with [11C]A-836339 did not evidence changes following neuroinflammation in rats , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[123] I. Buvat,et al. Evaluation of TSPO PET imaging, a marker of glial activation, to study the neuroimmune footprints of morphine exposure and withdrawal. , 2017, Drug and alcohol dependence.
[124] Frode Willoch,et al. Imaging of opioid receptors in the central nervous system , 2007, Brain : a journal of neurology.
[125] T. Bisogno,et al. Cannabinoids and the expanded endocannabinoid system in neurological disorders , 2019, Nature Reviews Neurology.
[126] H. Loh,et al. Molecular mechanisms and regulation of opioid receptor signaling. , 2000, Annual review of pharmacology and toxicology.
[127] J O Rinne,et al. Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study. , 2000, Archives of neurology.
[128] Takashi Kato,et al. Rat‐PET study without anesthesia: Anesthetics modify the dopamine D1 receptor binding in rat brain , 2004, Synapse.
[129] Jacob M. Hooker,et al. Cue-Induced Dopamine Release Predicts Cocaine Preference: Positron Emission Tomography Studies in Freely Moving Rodents , 2009, The Journal of Neuroscience.
[130] S. Ametamey,et al. Synthesis, radiolabeling and evaluation of novel 4-oxo-quinoline derivatives as PET tracers for imaging cannabinoid type 2 receptor. , 2015, European journal of medicinal chemistry.
[131] K. Ishii,et al. Assessment of adenosine A2A receptors with PET as a new diagnostic tool for neurological disorders , 2002 .
[132] Allan V. Kalueff,et al. Developing better and more valid animal models of brain disorders , 2015, Behavioural Brain Research.
[133] T. Suhara,et al. Utility of small-animal positron emission tomographic imaging of rats for preclinical development of drugs acting on the serotonin transporter. , 2009, The international journal of neuropsychopharmacology.
[134] A. Drzezga,et al. Imaging in Neurology Research II: PET Imaging of CNS Disorders , 2011 .
[135] R. Banati,et al. Lack of permanent nigrostriatal dopamine deficit following 6-hydroxydopamine injection into the rat striatum , 2005, Journal of Neural Transmission.
[136] I. Buvat,et al. Corrigendum to "Evaluation of TSPO PET imaging, a marker of glial activation, to study the neuroimmune footprints of morphine exposure and withdrawal" [Drug Alcohol Depend. 170 (2017) 43-50]. , 2019, Drug and alcohol dependence.
[137] V. Jevtovic-Todorovic,et al. Anesthesia induces neuronal cell death in the developing rat brain via the intrinsic and extrinsic apoptotic pathways , 2005, Neuroscience.
[138] R. Cilia. Molecular Imaging of the Cannabinoid System in Idiopathic Parkinson's Disease. , 2018, International review of neurobiology.
[139] B. Shyu,et al. A fMRI study of brain activations during non-noxious and noxious electrical stimulation of the sciatic nerve of rats , 2001, Brain Research.
[140] Bruce G. Jenkins,et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[141] F. Blankenberg,et al. Nuclear medicine applications in molecular imaging , 2002, Journal of magnetic resonance imaging : JMRI.
[142] J. Lever. PET and SPECT imaging of the opioid system: receptors, radioligands and avenues for drug discovery and development. , 2007, Current pharmaceutical design.
[143] L. Nummenmaa,et al. Opioid system and human emotions , 2018, British journal of pharmacology.
[144] I. Torres Espallardo,et al. PET/TAC: bases físicas, instrumentación y avances , 2017 .
[145] Koen Van Laere,et al. Widespread Decrease of Type 1 Cannabinoid Receptor Availability in Huntington Disease In Vivo , 2010, The Journal of Nuclear Medicine.
[146] Koen Van Laere,et al. In vivo type 1 cannabinoid receptor mapping in the 6-hydroxydopamine lesion rat model of Parkinson's disease , 2010, Brain Research.
[147] M. Bushnell,et al. Restraint training for awake functional brain scanning of rodents can cause long-lasting changes in pain and stress responses , 2016, Pain.
[148] S. Ziegler,et al. PET & SPECT instrumentation. , 2008, Handbook of experimental pharmacology.
[149] C. A. Marsden,et al. Functional magnetic resonance imaging studies of opioid receptor-mediated modulation of noxious-evoked BOLD contrast in rats , 2005, Psychopharmacology.
[150] Sean R. Donohue,et al. In vivo SPECT and ex vivo autoradiographic brain imaging of the novel selective CB1 receptor antagonist radioligand [125I]SD7015 in CB1 knock-out and wildtype mouse , 2013, Brain Research Bulletin.
[151] Armin Kolb,et al. Positron emission tomography/magnetic resonance imaging: the next generation of multimodality imaging? , 2008, Seminars in nuclear medicine.
[152] Roger Lecomte,et al. Small-Animal PET: What Is It, and Why Do We Need It?* , 2012, The Journal of Nuclear Medicine Technology.
[153] L. Bristow,et al. Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2. , 2003, Molecular pharmacology.
[154] Masahiro Fujita,et al. In vitro and in vivo evaluation of 11C-SD5024, a novel PET radioligand for human brain imaging of cannabinoid CB1 receptors , 2014, NeuroImage.
[155] C. Antke,et al. [State-of-the-art of small animal imaging with high-resolution SPECT]. , 2005, Nuklearmedizin. Nuclear medicine.
[156] Paul D Acton,et al. Small animal imaging with high resolution single photon emission tomography. , 2003, Nuclear medicine and biology.
[157] D. Muller,et al. Volatile Anesthetics Rapidly Increase Dendritic Spine Density in the Rat Medial Prefrontal Cortex during Synaptogenesis , 2010, Anesthesiology.
[158] B. Tsui,et al. Design and evaluation of two multi-pinhole collimators for brain SPECT , 2017, Annals of Nuclear Medicine.
[159] P. Vaska,et al. Preliminary Studies of a Simultaneous PET/MRI Scanner Based on the RatCAP Small Animal Tomograph , 2006, 2006 IEEE Nuclear Science Symposium Conference Record.
[160] H. Müller-Gärtner,et al. High Resolution SPECT in Small Animal Research , 2001, Reviews in the neurosciences.
[161] C. Antke,et al. DAT versus D2 receptor binding in the rat striatum: l‐DOPA‐induced motor activity is better predicted by reuptake than release of dopamine , 2016, Synapse.
[162] C. Antke,et al. Pharmacological challenge and synaptic response – assessing dopaminergic function in the rat striatum with small animal single-photon emission computed tomography (SPECT) and positron emission tomography (PET) , 2011, Reviews in the neurosciences.
[163] R. Gainetdinov,et al. The Physiology, Signaling, and Pharmacology of Dopamine Receptors , 2011, Pharmacological Reviews.
[164] C. Knoess,et al. PET-based molecular imaging in neuroscience , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[165] M. Verhoye,et al. Standardization of Small Animal Imaging—Current Status and Future Prospects , 2018, Molecular Imaging and Biology.
[166] U. Kumar,et al. Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System , 2018, International journal of molecular sciences.
[167] M. Khalil,et al. Molecular SPECT Imaging: An Overview , 2011, International journal of molecular imaging.
[168] Habib Zaidi,et al. Current Trends in Preclinical PET System Design. , 2007, PET clinics.
[169] H. Kung,et al. Characterization of IMPY as a potential imaging agent for β-amyloid plaques in double transgenic PSAPP mice , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[170] Ana Claudia Ranucci Durante,et al. Preclinical molecular imaging: development of instrumentation for translational research with small laboratory animals , 2016, Einstein.
[171] S. Arndt,et al. Evaluation of animal models of neurobehavioral disorders , 2009, Behavioral and Brain Functions.
[172] Donald W. Wilson,et al. FastSPECT II: a second-generation high-resolution dynamic SPECT imager , 2002, IEEE Transactions on Nuclear Science.
[173] Martine M. Mirrione,et al. Optimizing experimental protocols for quantitative behavioral imaging with 18F-FDG in rodents. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[174] Arend Heerschap,et al. Isoflurane anesthesia is a valuable alternative for α‐chloralose anesthesia in the forepaw stimulation model in rats , 2009, NMR in biomedicine.
[175] R. Franco,et al. Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders , 2016, Front. Neurosci..
[176] Steven H. Liang,et al. Synthesis and Preliminary PET Imaging Studies of a FAAH Radiotracer ([¹¹C]MPPO) Based on α-Ketoheterocyclic Scaffold. , 2016, ACS chemical neuroscience.
[177] W. Schultz. Multiple dopamine functions at different time courses. , 2007, Annual review of neuroscience.
[178] R J Jaszczak,et al. Single photon emission computed tomography (SPECT). Principles and instrumentation. , 1985, Investigative radiology.
[179] Jason S. Lewis,et al. Cu-ATSM: a radiopharmaceutical for the PET imaging of hypoxia. , 2007, Dalton transactions.
[180] In-vivo quantification of dose-dependent dopamine transporter blockade in the rat striatum with small animal SPECT , 2007, Nuclear medicine communications.
[181] O. Howes,et al. Single cocaine exposure does not alter striatal pre‐synaptic dopamine function in mice: an [18F]‐FDOPA PET study , 2017, Journal of neurochemistry.
[182] Ciprian Catana,et al. Small-Animal Molecular Imaging Methods , 2010, Journal of Nuclear Medicine.
[183] Zhen Yuan,et al. PET/SPECT molecular imaging in clinical neuroscience: recent advances in the investigation of CNS diseases. , 2015, Quantitative imaging in medicine and surgery.
[184] A Z Kyme,et al. Real-time 3D motion tracking for small animal brain PET , 2008, Physics in medicine and biology.
[185] T. Duong,et al. Regional Cerebral Blood Flow and BOLD Responses in Conscious and Anesthetized Rats under Basal and Hypercapnic Conditions: Implications for Functional MRI Studies , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[186] M. Pomper,et al. Serial imaging of human embryonic stem-cell engraftment and teratoma formation in live mouse models , 2009, Cell Research.
[187] S. Bhattacharyya,et al. Metallic radionuclides in the development of diagnostic and therapeutic radiopharmaceuticals. , 2011, Dalton transactions.
[188] Manuel Desco,et al. Automated Method for Small-Animal PET Image Registration with Intrinsic Validation , 2009, Molecular Imaging and Biology.
[189] Ralph Myers,et al. Small animal PET , 2002, European Neuropsychopharmacology.
[190] Jinhyung Kim,et al. Motor cortex stimulation and neuropathic pain: how does motor cortex stimulation affect pain-signaling pathways? , 2016, Journal of neurosurgery.
[191] M. Febo,et al. Functional connectivity, behavioral and dopaminergic alterations 24 hours following acute exposure to synthetic bath salt drug methylenedioxypyrovalerone , 2018, Neuropharmacology.
[192] C. Ferris,et al. Comparison of evoked cortical activity in conscious and propofol‐anesthetized rats using functional MRI , 1999, Magnetic resonance in medicine.
[193] P. Acton,et al. Occupancy of dopamine D2 receptors in the mouse brain measured using ultra-high-resolution single-photon emission tomography and [123I]IBF , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[194] W. Rogers,et al. SPECT instrumentation. , 1992, American journal of physiologic imaging.
[195] David Moratal,et al. Multi‐modal MRI classifiers identify excessive alcohol consumption and treatment effects in the brain , 2017, Addiction biology.
[196] P. Voorn,et al. Imaging of dopamine transporters in rats using high-resolution pinhole single-photon emission tomography , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[197] A. Soluri,et al. A new High-Resolution Imaging System (HiRIS2) detector for preclinical SPECT imaging , 2019, Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment.
[198] Frederic H Fahey,et al. Data acquisition in PET imaging. , 2002, Journal of nuclear medicine technology.
[199] A. Müller-Lutz,et al. GABAergic Control of Nigrostriatal and Mesolimbic Dopamine in the Rat Brain , 2018, Front. Behav. Neurosci..
[200] C. Antke,et al. GABAergic control of neostriatal dopamine D2 receptor binding and behaviors in the rat , 2017, Pharmacology Biochemistry and Behavior.
[201] Gary D Hutchins,et al. Small animal PET imaging. , 2004, ILAR journal.
[202] N. Volkow,et al. Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans , 1999, Psychopharmacology.
[203] Barry Setlow,et al. The Psychoactive Designer Drug and Bath Salt Constituent MDPV Causes Widespread Disruption of Brain Functional Connectivity , 2016, Neuropsychopharmacology.
[204] L. Mansi,et al. Small animal imaging facility: new perspectives for the radiologist , 2009, La radiologia medica.
[205] Linda A. Jelicks,et al. MicroPET/SPECT/CT imaging of small animal models of disease. , 2013, The American journal of pathology.
[206] Jeih-San Liow,et al. Imaging and Quantitation of Cannabinoid CB1 Receptors in Human and Monkey Brains Using 18F-Labeled Inverse Agonist Radioligands , 2010, Journal of Nuclear Medicine.
[207] Nils Schramm,et al. Quantitation of dopamine transporter blockade by methylphenidate: first in vivo investigation using [123I]FP-CIT and a dedicated small animal SPECT , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[208] Keiichi Oda,et al. Adenosine A2A receptor imaging with [11C]KF18446 PET in the rat brain after quinolinic acid lesion: Comparison with the dopamine receptor imaging , 2002, Annals of nuclear medicine.
[209] Xiaohua Zhu,et al. MRI-Driven PET Image Optimization for Neurological Applications , 2019, Front. Neurosci..
[210] A. Sullivan,et al. Growth/differentiation factor 5 protects nigrostriatal dopaminergic neurones in a rat model of Parkinson's disease , 1997, Neuroscience Letters.
[211] Markus Piel,et al. Positron emission tomography in CNS drug discovery and drug monitoring. , 2014, Journal of medicinal chemistry.